FDA panel recommends Zika testing of donated blood be relaxed

Jimmy 3x3 | 4 Views | 2017-12-01T18:40:45+00:00

(Reuters) - Advisers to the U.S. Food and Drug Administration on Friday recommended that the requirements for screening blood donations for the Zika virus be relaxed due to diminished risk of transfusion-transmitted infection.

The advisory panel voted that instead of requiring Zika virus testing on each individual blood donation, tests could be conducted on “mini-pools” in which blood samples are pooled before testing.

In 2016 the FDA advised U.S. blood centers to screen all blood donations for Zika.

Reporting by Toni Clarke in Washington; Editing by Cynthia Osterman

Our Standards:The Thomson Reuters Trust Principles.

Read Full News Here